Markets & Regulations


FDA says J&J COVID-19 vaccine is effective and safe

By Rachel Arthur

The FDA has outlined its analysis of Johnson & Johnson's single-shot COVID-19 vaccine, ahead of a meeting of the Vaccines and Related Biological Products Advisory Committee Meeting to assess the candidate's application for Emergency Use...

© GettyImages/image_jungle

Celltrion secures EU approval for its adalimumab biosimilar

By Jane Byrne

Celltrion’s adalimumab biosimilar, Yuflyma (CT-P17) has been approved by the European Commission for the treatment of multiple chronic inflammatory diseases, including rheumatoid arthritis, psoriasis, Crohn’s disease, and ulcerative colitis.

Follow us


View more